What is Lymphocyte-to-Monocyte Ratio (LMR)?

The Lymphocyte-to-Monocyte Ratio measures the relative number of lymphocytes and monocytes in the blood. It’s a quick indicator of immune balance and your body’s overall inflammatory status.

Why does it matter for long-term health and wellbeing?

A balanced LMR supports a well-regulated immune system, which is key for maintaining energy, recovery, and metabolic health. It helps identify how well your body adapts to stressors such as poor sleep, overtraining, or nutrient deficiencies.

What’s an optimal level of Lymphocyte-to-Monocyte Ratio?

Typical laboratory reference ranges for adults in Australia are around 2.0–5.0. The optimal range for proactive health and balanced immune function is generally 3.0–5.0, reflecting efficient regulation between immune response and recovery.

What influences Lymphocyte-to-Monocyte Ratio levels?

LMR can be affected by stress, sleep quality, physical activity, diet quality, and overall metabolic health. Factors that support immune resilience—such as nutrient-dense meals, adequate rest, and balanced exercise—help maintain healthy levels.

What does it mean if Lymphocyte-to-Monocyte Ratio is outside the optimal range?

If your LMR is lower than optimal, it may indicate that your immune system is under strain or that inflammatory activity is more dominant. Higher ratios can reflect strong immune regulation but should be viewed in the context of other biomarkers for accuracy.

How can I support healthy Lymphocyte-to-Monocyte Ratio levels?

Focusing on whole foods, regular physical activity, quality sleep, and effective stress management helps sustain immune balance. Tracking trends through repeat testing can help identify how your lifestyle choices affect immune performance over time.

This information is provided for general health and wellness purposes only and does not replace medical advice.

References

1. Bernardinello, N., Cianciulli, E., et al. (2022). The clinical relevance of lymphocyte to monocyte ratio in newly diagnosed idiopathic pulmonary fibrosis patients. Respiratory Medicine Journal, 187, 106561.
2. Chan, J. C. Y., Edwards, J., et al. (2017). The lymphocyte to monocyte ratio is a superior predictor of outcome compared with established biomarkers in patients undergoing curative resection for colorectal cancer. Annals of Surgery, 265(3), 539-545.
3. Piotrowski, D., Kalina, J., et al. (2020). Lymphocyte-To-Monocyte Ratio as the Best Simple Biomarker of Infection Among Several Leukocyte-Derived Ratios in Patients With Decompensated Liver Cirrhosis. International Journal of Environmental Research and Public Health, 17(5), 1727.
4. Tan, D., Gu J., et al. (2018). The lymphocyte to monocyte ratio, an inflammation‐based score, has prognostic value for tumour progression: a systematic review and meta‐analysis. Future Oncology, 14(19), 1897-1906.
5. Goto, W., Yamamoto, T., et al. (2018). Predictive value of lymphocyte‐to‐monocyte ratio in breast cancer patients treated with neoadjuvant chemotherapy: a retrospective study. BMC Cancer, 18, 505.